LivingGLP1
Study S001664

Biomarkers in Obese Patients With Knee Osteoarthritis Following Long-term Weight Maintenance

Registration

Registration
NCT02928614
Acronym
BIO-LOSEIT-II
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
QUADRUPLE
Status
COMPLETED
Enrollment
150
Start
2016-11
Primary completion
2019-02
Lead sponsor
Henrik Gudbergsen
Conditions
Osteoarthritis; Obesity
Interventions
DRUG:Liraglutide 3 mg (Saxenda); DRUG:Liraglutide 3 mg placebo
Results posted
FALSE

Registered primary outcomes

  • Change in collagen II degradation fragment α-C2M [Week 0 to 52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.